HOME >> BIOLOGY >> NEWS
UCSF Scientists Report On A Transcription Factor That Could Stimulate Heart Cells To Repair Damage Caused By Heart Attacks Or Birth Defects

Scientists at the University of California San Francisco have discovered a transcription factor that regulates part of the cycle that makes new copies of the cells in the human body. As more specifics are identified about the role of this and related cell cycle regulators, the knowledge may lead to new ways to stimulate repair of heart muscle cells after damage caused by a heart attack or birth defects.

Harold S. Bernstein, MD, PhD, assistant professor of pediatrics and investigator at the UCSF Cardiovascular Research Institute, reported on his research group's discoveries about human Cdc5 (hCdc5) on May 2 at the Pediatric Academic Societies' 1999 annual meeting in San Francisco.

The research, supported in part by the March of Dimes, is in its early stages. "The reason we are so interested in the cell cycle is that we need better treatments for children whose heart muscle is damaged due to heart abnormalities -- the most common form of birth defect." Bernstein said. If the work leads to a way to stimulate heart muscle repair, it also could help the 900,000 American adults struck with a heart attack each year. And because hCdc5 appears to regulate a crucial point in the cycle when cell duplication either halts or continues, knowledge about its actions could uncover potential new targets for drugs to stop the uncontrolled cell division in cancer.

Using recombinant DNA techniques, Bernstein cloned hCdc5 in 1997 and showed that it is a novel human protein involved in the division of human cells. Since then, he and his research team have shown that it binds to DNA and acts as a transcription factor -- it regulates genes that instruct a cell to start the final phase of cell division. Bernstein and the University of California have obtained a patent protecting the use of hCdc5 for therapeutic approaches to cancer and muscle disease.

In their presentation to the Society for Pediatric Research, Bernstein's team reports on work to identify specific sites
'"/>

Contact: Janet Basu
jbasu@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
3-May-1999


Page: 1 2 3 4

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/15/2019)... ... ... Deep Science Ventures (DSV), a new paradigm for applied science, today announced ... 100 companies over the next 10 years to address the urgent need for new ... was founded to create a better method for launching science companies; one that takes ...
(Date:8/15/2019)... ... , ... Serialization deadlines in the US and European Union ... becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing ... most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system capabilities. ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... June 17, 2019 , ... IVERIC bio, ... an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) vector for ... dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 related retinal ...
(Date:6/11/2019)... MONTREAL (PRWEB) , ... June 10, 2019 , ... ... growth of its distribution network with the appointment of Biofeedback Tech Ltd ... physiological monitoring systems are an essential part of many therapeutic treatments and clinical ...
(Date:6/11/2019)... Md. and ROANOKE, Va. (PRWEB) , ... June ... ... care optimized for microlearning engagement, and Carilion Clinic, a national leader in opioid ... the latest in virtual care. , Mytonomy recently deployed its virtual ...
(Date:6/6/2019)... (PRWEB) , ... June 05, 2019 , ... WCCT ... and medical device industries, announced today that they will be receiving 3 awards at ... Diego, CA. WCCT received 2 awards in the categories of overall Quality and Compatibility ...
Breaking Biology Technology:
Cached News: